These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 36690556)

  • 1. In Vitro Treatment of Extracorporeal Membrane Oxygenation Coagulopathy with Recombinant von Willebrand Factor or Lyophilized Platelets.
    Mazzeffi M; Gonzalez-Almada A; Wargowsky R; Ting L; Moskowitz K; Hockstein M; Davison D; Levy JH; Tanaka KA
    J Cardiothorac Vasc Anesth; 2023 Apr; 37(4):522-527. PubMed ID: 36690556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vitro Comparison of Recombinant and Plasma-Derived von Willebrand Factor Concentrate for Treatment of Acquired von Willebrand Syndrome in Adult Extracorporeal Membrane Oxygenation Patients.
    Mazzeffi M; Henderson R; Krause E; Rabin J; Madathil R; Chow J; Grazioli A; Meyer M; Wu Z; Tanaka K
    Anesth Analg; 2022 Feb; 134(2):312-321. PubMed ID: 34903705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Von Willebrand Factor-GP1bα Interactions in Venoarterial Extracorporeal Membrane Oxygenation Patients.
    Mazzeffi M; Hasan S; Abuelkasem E; Meyer M; Deatrick K; Taylor B; Kon Z; Herr D; Tanaka K
    J Cardiothorac Vasc Anesth; 2019 Aug; 33(8):2125-2132. PubMed ID: 30595484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Von Willebrand Factor Concentrate Administration for Acquired Von Willebrand Syndrome- Related Bleeding During Adult Extracorporeal Membrane Oxygenation.
    Mazzeffi M; Bathula A; Tabatabai A; Menaker J; Kaczorowski D; Madathil R; Galvagno S; Pasrija C; Rector R; Tanaka K; Herr D
    J Cardiothorac Vasc Anesth; 2021 Mar; 35(3):882-887. PubMed ID: 32758410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanical circulatory support is associated with loss of platelet receptors glycoprotein Ibα and glycoprotein VI.
    Lukito P; Wong A; Jing J; Arthur JF; Marasco SF; Murphy DA; Bergin PJ; Shaw JA; Collecutt M; Andrews RK; Gardiner EE; Davis AK
    J Thromb Haemost; 2016 Nov; 14(11):2253-2260. PubMed ID: 27601054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracorporeal membrane oxygenation induces short-term loss of high-molecular-weight von Willebrand factor multimers.
    Tauber H; Ott H; Streif W; Weigel G; Loacker L; Fritz J; Heinz A; Velik-Salchner C
    Anesth Analg; 2015 Apr; 120(4):730-6. PubMed ID: 25565317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracorporeal membrane oxygenation seems to induce impairment of primary hemostasis pathology as measured by a Multiplate analyzer: An observational retrospective study.
    Garaj M; Durila M; Vajter J; Solcova M; Marecek F; Hrachovinová I
    Artif Organs; 2022 May; 46(5):899-907. PubMed ID: 34904233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired von Willebrand syndrome and impaired platelet function during venovenous extracorporeal membrane oxygenation: Rapid onset and fast recovery.
    Kalbhenn J; Schlagenhauf A; Rosenfelder S; Schmutz A; Zieger B
    J Heart Lung Transplant; 2018 Aug; 37(8):985-991. PubMed ID: 29650295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of recombinant versus plasma-derived von Willebrand factor on prolonged PFA closure times in ECMO patients with acquired von Willebrand syndrome - an observational study.
    Büchsel M; Geisen U; Beckenkamp C; Wengenmayer T; Zieger B; Westermann D; Siegel PM
    Thromb J; 2023 Jan; 21(1):4. PubMed ID: 36627675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombus formation during ECMO: Insights from a detailed histological analysis of thrombus composition.
    Staessens S; Moussa MD; Pierache A; Rauch A; Rousse N; Boulleaux E; Ung A; Desender L; Pradines B; Vincentelli A; Mercier O; Labreuche J; Duhamel A; Van Belle E; Vincent F; Dupont A; Vanhoorelbeke K; Corseaux D; De Meyer SF; Susen S
    J Thromb Haemost; 2022 Sep; 20(9):2058-2069. PubMed ID: 35703468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accumulations of von Willebrand factor within ECMO oxygenators: Potential indicator of coagulation abnormalities in critically ill patients?
    Steiger T; Foltan M; Philipp A; Mueller T; Gruber M; Bredthauer A; Krenkel L; Birkenmaier C; Lehle K
    Artif Organs; 2019 Nov; 43(11):1065-1076. PubMed ID: 31192471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet Phenotype and Function Changes With Increasing Duration of Extracorporeal Membrane Oxygenation.
    Van Den Helm S; Yaw HP; Letunica N; Barton R; Weaver A; Newall F; Horton SB; Chiletti R; Johansen A; Best D; McKittrick J; Butt W; d'Udekem Y; MacLaren G; Linden MD; Ignjatovic V; Monagle P
    Crit Care Med; 2022 Aug; 50(8):1236-1245. PubMed ID: 35020670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective observational study of hemostatic alterations during adult extracorporeal membrane oxygenation (ECMO) using point-of-care thromboelastometry and platelet aggregometry.
    Nair P; Hoechter DJ; Buscher H; Venkatesh K; Whittam S; Joseph J; Jansz P
    J Cardiothorac Vasc Anesth; 2015 Apr; 29(2):288-96. PubMed ID: 25655210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The physical spacing between the von Willebrand factor D'D3 and A1 domains regulates platelet adhesion in vitro and in vivo.
    Zhang C; Kelkar A; Nasirikenari M; Lau JTY; Sveinsson M; Sharma UC; Pokharel S; Neelamegham S
    J Thromb Haemost; 2018 Mar; 16(3):571-582. PubMed ID: 29251812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different mechanisms of oxygenator failure and high plasma von Willebrand factor antigen influence success and survival of venovenous extracorporeal membrane oxygenation.
    Steiger T; Philipp A; Hiller KA; Müller T; Lubnow M; Lehle K
    PLoS One; 2021; 16(3):e0248645. PubMed ID: 33735282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of high mechanical shear stress and oxygenator membrane surface on blood damage relevant to thrombosis and bleeding in a pediatric ECMO circuit.
    Sun W; Wang S; Chen Z; Zhang J; Li T; Arias K; Griffith BP; Wu ZJ
    Artif Organs; 2020 Jul; 44(7):717-726. PubMed ID: 31970795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation.
    Michels A; Swystun LL; Mewburn J; Albánez S; Lillicrap D
    J Vis Exp; 2017 Aug; (126):. PubMed ID: 28829426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early diagnosis of acquired von Willebrand Syndrome (AVWS) is elementary for clinical practice in patients treated with ECMO therapy.
    Kalbhenn J; Schmidt R; Nakamura L; Schelling J; Rosenfelder S; Zieger B
    J Atheroscler Thromb; 2015; 22(3):265-71. PubMed ID: 25186021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desmopressin treatment improves platelet function under flow in patients with postoperative bleeding.
    Swieringa F; Lancé MD; Fuchs B; Feijge MA; Solecka BA; Verheijen LP; Hughes KR; van Oerle R; Deckmyn H; Kannicht C; Heemskerk JW; van der Meijden PE
    J Thromb Haemost; 2015 Aug; 13(8):1503-13. PubMed ID: 25988848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Device-induced platelet dysfunction in mechanically assisted circulation increases the risks of thrombosis and bleeding.
    Chen Z; Zhang J; Kareem K; Tran D; Conway RG; Arias K; Griffith BP; Wu ZJ
    Artif Organs; 2019 Aug; 43(8):745-755. PubMed ID: 30805954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.